NCT02660229View on ClinicalTrials.gov

An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Cancer Pain

Interventions

DRUG

Oxycodone Hydrochloride

Oxycodone injection

DRUG

Morphine Sulphate

Morphine sulphate injection

Trial Locations (1)

Unknown

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul

All Listed Sponsors

lead

Mundipharma Korea Ltd

INDUSTRY

NCT02660229 - An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion. | Biotech Hunter | Biotech Hunter